DIH Holding US (OTCMKTS:DHAI – Get Free Report) and Brainsway (NASDAQ:BWAY – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Insider and Institutional Ownership
27.8% of DIH Holding US shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 27.0% of DIH Holding US shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for DIH Holding US and Brainsway, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DIH Holding US | 1 | 0 | 0 | 0 | 1.00 |
| Brainsway | 0 | 2 | 5 | 0 | 2.71 |
Profitability
This table compares DIH Holding US and Brainsway’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DIH Holding US | N/A | N/A | N/A |
| Brainsway | 15.65% | 12.74% | 8.17% |
Risk & Volatility
DIH Holding US has a beta of -6.5, indicating that its share price is 750% less volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.
Valuation and Earnings
This table compares DIH Holding US and Brainsway”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DIH Holding US | $62.86 million | 0.00 | -$8.68 million | ($4.94) | -0.00 |
| Brainsway | $52.22 million | 10.90 | $7.57 million | $0.44 | 32.16 |
Brainsway has lower revenue, but higher earnings than DIH Holding US. DIH Holding US is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.
Summary
Brainsway beats DIH Holding US on 12 of the 14 factors compared between the two stocks.
About DIH Holding US
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
About Brainsway
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Receive News & Ratings for DIH Holding US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIH Holding US and related companies with MarketBeat.com's FREE daily email newsletter.
